References

 

1.     Vaz SC, Woll JPP, Cardoso F, Groheux D, Cook GJR, Ulaner GA, Jacene H, Rubio T, Schoones JW, Peeters MV, Poortmans P, Mann RM, Graff SL, Dibble EH, de Geus-Oei LF. Joint EANM-SNMMI guideline on the role of [18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2706-2732.doi: 10.1007/s00259-024-06696-9 . 

2.     Sachpekidis C, Weru V, Kopp-Schneider A, Hassel JC, Dimitrakopoulou-Strauss A. The prognostic value of [¹⁸F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2699-2714. doi: 10.1007/s00259-023-06243-y.

3.     Khandelwal Y, Singh Parihar A, Sistani G, Ramirez-Fort MK, Zukotynski K, Subramaniam RM. Role of PET/Computed Tomography in Gastric and Colorectal Malignancies. PET Clin. 2024 Apr;19(2):177-186. doi: 10.1016/j.cpet.2023.12.004.

4.     Mari A, Cadenar A, Giudici S, Cianchi G, Albisinni S, Autorino R, Di Maida F, Gandaglia G, Mir MC, Valerio M, Marra G, Zattoni F, Bianchi L, Lombardo R, Shariat SF, Roupret M, Bauckneht M, Vaggelli L, De Nunzio C, Minervini A. Asystematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer. Prostate Cancer Prostatic Dis.2025 Mar;28(1):56-69. doi: 10.1038/s41391-024-00850-y.

5.     Boekestijn I, van Oosterom MN, Dell'Oglio P, van Velden FHP, Pool M, Maurer T, Rietbergen DDD, Buckle T, van Leeuwen FWB. The current status and future prospects for molecular imaging-guided precision surgery. Cancer Imaging. 2022Sep 6;22(1):48. doi: 10.1186/s40644-022-00482-2.

6.     Buckle T, Rietbergen DDD, de Wit-van der Veen L, Schottelius M. Lessons learned in application driven imaging agent design for image-guided surgery. Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3040-3054. doi: 10.1007/s00259-024-06791-x.

7.     Giammarile F, Vidal-Sicart S, Paez D, Pellet O, Enrique EL, Mikhail-Lette M, Morozova O, Maria Camila NM, Diana Ivonne RS, Delgado Bolton RC, Valdés Olmos RA, Mariani G. Sentinel Lymph Node Methods in Breast Cancer. Semin Nucl Med.2022 Sep;52(5):551-560. doi: 10.1053/j.semnuclmed.2022.01.006.

8.     de Boniface J, Filtenborg Tvedskov T, Rydén L, Szulkin R, Reimer T, Kühn T, Kontos M, Gentilini OD, Olofsson Bagge R, Sund M, Lundstedt D, Appelgren M, Ahlgren J, Norenstedt S, Celebioglu F, Sackey H, Scheel Andersen I, Hoyer U, Nyman PF, Vikhe Patil E, Wieslander E, Dahl Nissen H, Alkner S, Andersson Y, Offersen BV, Bergkvist L, Frisell J, Christiansen P; SENOMAC Trialists’ Group; SENOMAC Trialists' Group. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases. N Engl J Med. 2024 Apr 4;390(13):1163-1175. 10.1056/NEJMoa2313487

9.    Witteveen SJ, Klop WMC, van Dijk-de Haan MC, Karssemakers LHE. Melanoma in the head and neck region: the value of preoperative imaging in melanoma stage I-II. Melanoma Res. 2025 Apr 1;35(2):115-121. Doi: 10.1097/CMR.0000000000001013.

10.     Pennington TE, Thompson JF. Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on Dixon et al. Primary Cutaneous Melanoma-Management in 2024. J. Clin. Med. 2024; 13: 1607. J Clin Med. 2025 Jan 2;14(1):215. doi: 10.3390/jcm14010215.

11.    Singh A, Roy S, Tuljapurkar V, Nair D, Chaturvedi P. Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer. Curr Oncol Rep. 2022 Jun; 24(6):783-791. doi: 10.1007/s11912-021-01171-2.

14.     Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M. Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Eur Urol. 2015 Sep;68(3):530-4. doi: 10.1016/j.eururo.2015.04.034.

13.     Kunert JP, Müller M, Günther T, Stopper L, Urtz-Urban N, Beck R, Wester HJ. Synthesis and preclinical evaluation of novel ^99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI Res. 2023 Jan16;13(1):2. doi: 10.1186/s13550-022-00942-7.

14.    Berrens AC, Scheltema M, Maurer T, Hermann K, Hamdy FC, Knipper S, Dell'Oglio P, Mazzone E, de Barros HA, Sorger JM, van Oosterom MN, Stricker PD, van Leeuwen PJ, Rietbergen DDD, Valdes Olmos RA, Vidal-Sicart S, Carroll PR, Buckle T, van der Poel HG, van Leeuwen FWB. Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel. Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):2893-2902. doi: 10.1007/s00259-023-06524-6

15.    Heidkamp J,  Scholte M,  Rosman C,  Manohar S,  Fütterer JJ,  Rovers MM. Novel imaging techniques for intraoperative margin assessment in surgical oncology: A systematic review.  Int. J. Cancer.  2021; 149: 635-645. https://doi.org/10.1002/ijc.33570.

16.    Vries HM, Bekers E, van Oosterom MN, Karakullukcu MB, van HG, Poel D, van Leeuwen FWB, Buckle T, Brouwer OR. c-MET Receptor-Targeted Fluorescence on the Road to Image-Guided Surgery in Penile Squamous Cell Carcinoma Patients. J Nucl Med. 2022 Jan;63(1):51-56. doi: 10.2967/jnumed.120.261864.

17.    Droste MF, van Velden FHP, van Oosterom MN, Luijk VJ, Burgmans MC, Buckle T, van Leeuwen FWB, Rietbergen DDD. Augmenting CT-Guided Bone Biopsies Using 18F-FDG PET/CT Guidance. Cancers (Basel). 2024 Jul 29;16(15):2693. doi: 10.3390/cancers16152693.

18.    Rietbergen DDD, Meershoek P, van Oosterom MN, Roestenberg M, van Erkel AR, Smit F, van der Hage JA, Valdés Olmos RA, van Leeuwen FWB. Freehand-SPECT with 99mTc-HDP as tool to guide percutaneous biopsy of skeletal lesions detected on bone scintigraphy. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jul-Aug;38(4):218-223. doi: 10.1016/j.remn.2019.01.003.

19.    Checcucci E, Bauckneht M, Cisero E, Volpi G, Rizzo A, Zattoni F, Bianchi L, De Angelis M, Cangemi D, Heetman J, Farolfi A, Piramide F, De Cillis S, Amparore D, De Luca S, Di Dio M, Dal Moro F, Fanti S, Schiavina R, Briganti A, Fiori C, Gandaglia G, Porpiglia F. PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort. Urology. 2025 Feb;196:178-185. doi: 10.1016/j.urology.2024.10.026.CHECCUCCI, Enrico, et al. PSMA PET-targeted biopsy for prostate cancer diagnosis: initial experience from a multicenter cohort. Urology, 2025, 196: 178-185.https://doi.org/10.1016/j.urology.2024.10.026 

20.    Vollmer I, Páez-Carpio A, Sánchez-Lorente D, Boada M, Martínez D, Sánchez M, Sánchez-Izquierdo N, Tormo-Ratera M, Ribera-Perianes J, Vidal-Sicart S, Carrero- Cardenal E, Paredes P. Preoperative localization of lung nodules: a comparative analysis of hookwire and radio-guided procedures. J Thorac Dis. 2022 Nov;14(11):4329-4340. doi: 10.21037/jtd-22-552. 

21.    Cebrecos I, Sánchez-Izquierdo N, Ganau S, Mensión E, Perissinotti A, Úbeda B, Bargalló X, Alonso I, Vidal-Sicart S. Radioactive and non-radioactive seeds as surgical localization method of non-palpable breast lesions. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Mar-Apr;41(2):100-107. doi: 10.1016/j.remnie.2022.01.002.

22.    de la Riva Pérez PA, Carrera Salazar D, Paredes Barranco P, Goñi Gironés E. Survey of the Radioguided Surgery Working Group (GTCRG-RGSWG) of the Spanish  Society of Nuclear Medicine and Molecular Imaging (SEMNIM): Radioguided localization of non-palpable breast lesions with or without indication for selective sentinel node biopsy: ROLL, SNOLL and 125I seeds. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Jul-Aug;41(4):223-230. doi: 10.1016/j.remnie.2022.05.014. 

23.    Rella R, Conti M, Bufi E, Trombadori CML, Di Leone A, Terribile D, Masetti R, Zagaria L, Mulè A, Morciano F, Franceschini G, Belli P. Selective Axillary Dissection after Neoadjuvant Chemotherapy in Patients with Lymph-Node-Positive Breast Cancer (CLYP Study): The Radio-Guided Occult Lesion Localization Technique for Biopsy-Proven Metastatic Lymph Nodes. Cancers (Basel). 2023 Mar 29;15(7):2046. doi: 10.3390/cancers15072046.

24.    Hendriks P, Rietbergen DDD, van Erkel AR, Coenraad MJ, Arntz MJ, Bennink RJ, Braat AE, Crobach S, van Delden OM, Dibbets-Schneider P, van der Hulle T, Klümpen HJ, van der Meer RW, Nijsen JFW, van Rijswijk CSP, Roosen J, Ruijter BN, Smit F, Stam MK, Takkenberg RB, Tushuizen ME, van Velden FHP, de Geus-Oei LF, Burgmans MC; Dutch Hepatocellular and Cholangiocarcinoma Group. Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2085-2097. doi: 10.1007/s00259-024-06630-z.

25.    Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, Gnesin S, Bodei L, Kracmerova T, Luster M, Garin E, Herrmann K. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1682-1699. doi: 10.1007/s00259-021-05600-z.

26.    van Leeuwen FWB, Schottelius M, Brouwer OR, Vidal-Sicart S, Achilefu S, Klode J, et al. Trending: Radioactive and Fluorescent Bimodal/Hybrid Tracers as Multiplexing Solutions for Surgical Guidance. J Nucl Med. 2020;61(1):13–9. doi: 10.2967/jnumed.119.228684.

27.    van Leeuwen FW, Hardwick JC, van Erkel AR. Luminescence-based Imaging Approaches in the Field of Interventional Molecular Imaging. Radiology. 2015;276(1):12–29.10.1148/radiol.2015132698

28.    Wang S, Yang W, Deng J, Zhang J, Ma F, Wang J. Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of (99m)Tc-HYNIC-octreotide SPECT/CT and radio guidance with a hand-held γ-probe during surgery. Nucl Med Commun. 2013;34(3):249–53. 10.1097/MNM.0b013e32835bdfc9

29.    Cuccurullo V, Di Stasio GD, Mansi L. Radioguided surgery with radiolabelled  somatostatin analogue s: not only in GEP-NETs. Nuclear Medicine Review. 2017;20(1):49–56.10.5603/NMR.2017.0003

30.    Hensbergen AW, van Willigen DM, van Beurden F, van Leeuwen PJ, Buckle T, Schottelius M, et al. Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specifc-Membrane-AntigenTargeted Tracers? Bioconjug Chem. 2020;31(2):375–95.10.1021/acs.bioconjchem.9b00758

31.    Meershoek P, Buckle T, van Oosterom MN, KleinJan GH, van der Poel HG, van Leeuwen FWB. Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked? J Nucl Med 2020;61:834–41. https://doi.org/10.2967/jnumed.119.235234.

32.    Fragoso Costa, P., Shi, K., Holm, S. et al. Surgical radioguidance with beta-emitting radionuclides; challenges and possibilities: A position paper by the EANM. Eur J Nucl Med Mol Imaging 51, 2903–2921 (2024). https://doi.org/10.1007/s00259-023-06560-2

33.    Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822. doi: 10.1007/s00259-021-05334-y.

34.    Garbaccio V, Menga M, Mensa G, Passera R, Galati A, Codegone A, Finessi M, Pilati E, Deandreis D, Pellerito RE. Impact of radioguided occult lesion localization in the management of cervical recurrences from differentiated thyroid cancer. Q J Nucl Med Mol Imaging. 2022 Mar;66(1):43-51. doi: 10.23736/S1824-4785.17.03027-8.

35.    Cockburn KC, Toumi Z, Mackie A, Julyan P. Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review. J Gastrointest Surg. 2021 Dec;25(12):3244-3257. doi: 10.1007/s11605-021-05115-w.

36.    Rama Alonso S, Campaña Díaz E, Blanco Blanco JF, García-Talavera San Miguel P, Gómez-Caminero López F. Targeted Sacral Biopsy With Portable Gamma Camera and Intraoperative Gamma Probe. Clin Nucl Med. 2024 Oct 1;49(10):e513-e514. doi: 10.1097/RLU.0000000000005370.

37.    Horn T, Krönke M, Rauscher I, Haller B, Robu S, Wester H-J, et al. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favourable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer. Eur Urol 2019; 76:517–23. doi.org/10.1016/j.eururo.2019.03.045.

38.    Mansur A, Habibollahi P, Fang A, Mahvash A, Etezadi V, Liddell RP, Camacho JC, Cohen EI, Kokabi N, Arepally A, Georgiades C, Nezami N. New frontiers in radioembolization. Ther Adv Med Oncol. 2024 Sep 30;16:17588359241280692. doi: 10.1177/17588359241280692.

39.    Lambert B, Vergucht V, Dekeyser S, De Craene A, Ameye F, Van Den Bossche B, Berwouts D, Mertens J, Vanoverschelde H, Coppens M, Gabriel C, Rottiers M, Van Haverbeke C, Dekuyper P, De Backer P, Carels K, Van Oostveldt T, Decaestecker K. Feasibility study on the implementation of a mobile high-resolution PET/CT scanner for surgical specimens: exploring clinical applications and practical considerations. Eur J Nucl Med Mol Imaging. 2025 Feb 20. doi: 10.1007/s00259-025-07143-z.

40.    Barletta F, Ceci F, van den Bergh RCN, Rajwa P, Montorsi F, Briganti A, Gandaglia G; EAU-YAU Prostate Cancer Working Party. The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting. Curr Opin Urol. 2023 Nov 1;33(6):502-509. doi:10.1097/MOU.0000000000001118. Epub 2023 Aug 2. PMID: 37530704.

41.    van Dam MA, Vuijk FA, Stibbe JA, Houvast RD, Luelmo SAC, Crobach S, Shahbazi Feshtali S, de Geus-Oei LF, Bonsing BA, Sier CFM, Kuppen PJK, Swijnenburg RJ, Windhorst AD, Burggraaf J, Vahrmeijer AL, Mieog JSD. Overview and Future Perspectives on Tumour-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers (Basel). 2021 Dec 2;13(23):6088. doi: 10.3390/cancers13236088

42.    El Lakis M, Gianakou A, Nockel P, Wiseman D, Tirosh A, Quezado MA, et al. Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumours. JAMA Surg 2019;154:40–5. https://doi.org/10.1001/jamasurg.2018.3475.

43.    Pisano G, van Oosterom MN, Berrens AC, Slof LJ, Rietbergen DDD, van der Poel HG, van Leeuwen PJ, van Leeuwen FWB. Freehand SPECT Combined with 3-Dimensional Light Detection and Ranging as Alternative Means of Specimen Scanning During Prostate Cancer Surgery. J Nucl Med. 2024 Nov 1;65(11):1816-1817. doi: 10.2967/jnumed.124.268256.

44.    Collamati F, Morganti S, van Oosterom MN, Campana L, Ceci F, Luzzago S, Mancini-Terracciano C, Mirabelli R, Musi G, Nicolanti F, Orsi I, van Leeuwen FWB, Faccini R. First-in-human validation of a DROP-IN β-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithm. Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3098-3108. doi: 10.1007/s00259-024-06653-6. 

45.    Berrens AC, Knipper S, Marra G, van Leeuwen PJ, van der Mierden S, Donswijk ML, Maurer T, van Leeuwen FWB, van der Poel HG. State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic Review. Eur Urol Open Sci. 2023 Jun 16;54:43-55. doi: 10.1016/j.euros.2023.05.014.

46.    Mayr R, Engelmann SU, Yang Y, Haas M, Schmid T, Schnabel MJ, Breyer J, Schmidt D, Eiber M, Denzinger S, Burger M, Hellwig D, Moosbauer J, Grosse J. Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients. World J Urol. 2024 Aug 12;42(1):483. doi: 10.1007/s00345-024-05189-6.

47.    Dell'Oglio P, Meershoek P, Maurer T, Wit EMK, van Leeuwen PJ, van der Poel HG, van Leeuwen FWB, van Oosterom MN. A DROP-IN Gamma Probe for Robot-assisted Radioguided Surgery of Lymph Nodes During Radical Prostatectomy. Eur Urol. 2021 Jan;79(1):124-132. doi: 10.1016/j.eururo.2020.10.031. Epub 2020 Nov 14. PMID: 33203549.

48.    Azargoshasb S, Houwing KHM, Roos PR, van Leeuwen SI, Boonekamp M, Mazzone E, Bauwens K, Dell'Oglio P, van Leeuwen FWB, van Oosterom MN. Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery. J Nucl Med. 2021 Sep 1;62(9):1314-1317. doi: 10.2967/jnumed.120.259796.

49.    Dell'Oglio P, van Willigen DM, van Oosterom MN, Bauwens K, Hensbergen F, Welling MM, van der Stadt H, Bekers E, Pool M, van Leeuwen P, Maurer T, van Leeuwen FWB, Buckle T. Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model. EJNMMI Res. 2022 Mar 7;12(1):14. doi: 10.1186/s13550-022-00886-y.

50.  Eder, AC., Omrane, M.A., Stadlbauer, S. et al. The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging. Eur J Nucl Med Mol Imaging 2021; 48: 2057–2058. doi.org/10.1007/s00259-020-05184-0.

51.    KleinJan GH, van Werkhoven E, van den Berg NS, Karakullukcu MB, Zijlmans HJMAA, van der Hage JA, van de Wiel BA, Buckle T, Klop WMC, Horenblas S, Valdés Olmos RA, van der Poel HG, van Leeuwen FWB. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1915-1925. doi: 10.1007/s00259-018-4028-x.

52.    van Oosterom MN, Meershoek P, Welling MM, Pinto F, Matthies P, Simon H, et al. Extending the Hybrid Surgical Guidance Concept With Freehand Fluorescence Tomography. IEEE Trans Med Imaging 2020;39:226–35. doi.org/10.1109/TMI.2019.2924254.

53.    Mazzone E, Dell'Oglio P, Grivas N, Wit E, Donswijk M, Briganti A, Leeuwen FV, Poel HV. Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer. J Nucl Med. 2021 Oct;62(10):1363-1371. doi: 10.2967/jnumed.120.259788.

54.    Dell'Oglio P, de Vries HM, Mazzone E, KleinJan GH, Donswijk ML, van der Poel HG, Horenblas S, van Leeuwen FWB, Brouwer OR. Hybrid Indocyanine Green-99mTc-nanocolloid for Single-photon Emission Computed Tomography and Combined Radio- and Fluorescence-guided Sentinel Node Biopsy in Penile Cancer: Results of 740 Inguinal Basins Assessed at a Single Institution. Eur Urol. 2020 Dec;78(6):865-872. doi: 10.1016/j.eururo.2020.09.007.

55.    Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, Audisio RA, Zoras O, Lassmann M, Chakera AH, Uren R, Chondrogiannis S, Colletti PM, Rubello D. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1750-1766. doi: 10.1007/s00259-015-3135-1.

56.    Petousis S, Christidis P, Margioula-Siarkou C, Liberis A, Vavoulidis E, Margioula-Siarkou G, Vatopoulou A, Papanikolaou A, Mavromatidis G, Dinas K. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis. Arch Gynecol Obstet. 2022 Oct;306(4):1221-1234. doi: 10.1007/s00404-022-06458-8.

57.    Giammarile F, Schilling C, Gnanasegaran G, Bal C, Oyen WJG, Rubello D, Schwarz T, Tartaglione G, Miller RN, Paez D, van Leeuwen FWB, Valdés Olmos RA, McGurk M, Delgado Bolton RC. The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):623-637. doi: 10.1007/s00259-018-4235-5.

58.     Collarino A, Vidal-Sicart S, Perotti G, Valdés Olmos RA. The sentinel node approach in gynaecological malignancies. Clin Transl Imaging. 2016;4(5):411-420. doi: 10.1007/s40336-016-0187-6.

59.    Brouwer OR, Albersen M, Parnham A, Protzel C, Pettaway CA, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J, Fernández-Pello S, Greco I, van der Heijden MS, Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Garcia-Perdomo HA, Rumble RB, Sachdeva A, Sakalis VI, Zapala Ł, Sánchez Martínez DF, Spiess PE, Tagawa ST. European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. Eur Urol. 2023 Jun;83(6):548-560. doi: 10.1016/j.eururo.2023.02.027.

60.    Wit EMK, Acar C, Grivas N, Yuan C, Horenblas S, Liedberg F, Valdes Olmos RA,van Leeuwen FWB, van den Berg NS, Winter A, Wawroschek F, Hruby S, Janetschek G, Vidal-Sicart S, MacLennan S, Lam TB, van der Poel HG. Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy. Eur Urol. 2017 Apr;71(4):596-605. doi: 10.1016/j.eururo.2016.09.007.

61.    Chiang S, Tessier-Cloutier B, Klein E, Ardon O, Mueller JJ, Leitao MM Jr, Abu-Rustum NR, Ellenson LH. Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer. Int J Gynecol Cancer. 2024 May 6;34(5):681-688. doi: 10.1136/ijgc-2023-005157. PMID: 38388180.

62.    Mauro J, Viveros-Carreño D, Vizzielli G, De Ponti E, Fanfani F, Ramirez PT, Buda A. Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review. Int J Gynecol Cancer. 2023 Sep 4;33(9):1370-1375. doi: 10.1136/ijgc-2023-004692. PMID: 37586759.

63.    Di Berardino S, Capolupo GT, Caricato C, Caricato M. Sentinel lymph node mapping procedure in T1 colorectal cancer: A systematic review of published studies. Medicine (Baltimore). 2019 Jul;98(28):e16310. doi: 10.1097/MD.0000000000016310.

64.    Rietbergen DD, van Oosterom MN, Kleinjan GH, Brouwer OR, Valdes-Olmos RA, VAN Leeuwen FW, Buckle T. Interventional nuclear medicine: a focus on radioguided intervention and surgery. Q J Nucl Med Mol Imaging. 2021 Mar;65(1):4-19. doi: 10.23736/S1824-4785.21.03286-6.

65.    Van Oosterom MN, Rietbergen DDD, Welling MM, Van Der Poel HG, Maurer T, Van Leeuwen FWB. Recent advances in nuclear and hybrid detection modalities for image-guided surgery. Expert Rev Med Devices. 2019 Aug;16(8):711-734. doi: 10.1080/17434440.2019.1642104.

66.    Van Den Berg NS, Buckle T, Kleinjan GI, Klop WM, Horenblas S, Van Der Poel HG, Valdés-Olmos RA, Van Leeuwen FW. Hybrid tracers for sentinel node biopsy. Q J Nucl Med Mol Imaging. 2014 Jun;58(2):193-206.PMID: 24835293

67.    KleinJan, G.H., Karakullukçu, B., Klop, W.M.C, Engelen T, van den Berg NS, van Leeuwen FWB. Introducing navigation during melanoma-related sentinel lymph node procedures in the head-and-neck region. EJNMMI Res 2017; 7: 65. doi.org/10.1186/s13550-017-0312-1.

68.    Zarifmahmoudi L, Aghaee A, Treglia G, Sadeghi R. Sentinel lymph node mapping in breast cancer patients following neoadjuvant chemotherapy: systematic review and meta-analysis about head to head comparison of cN0 and cN + patients. Breast Cancer. 2022 Jan;29(1):50-64. doi: 10.1007/s12282-021-01280-7.

69.    Harrison C, Rodrigues JN, Cassell O. Inter-operator variability in the sensitivity of sentinel lymph node biopsy for melanoma. J Plast Reconstr Aesthet Surg 2018;71:1816–34. https://doi.org/10.1016/j.bjps.2018.07.034.

70.    KleinJan GH, Bunschoten A, van den Berg NS, Olmos RA, Klop WM, Horenblas S, van der Poel HG, Wester HJ, van Leeuwen FW. Fluorescence guided surgery and tracer-dose, fact or fiction? Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1857-67. doi: 10.1007/s00259-016-3372-y.

71.    Heuveling DA, Karagozoglu KH, Van Lingen A, Hoekstra OS, Van Dongen GAMS, De Bree R. Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe. EJNMMI Res 2018;8. https://doi.org/10.1186/s13550-018-0368-6.

72.    Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M. Prostate- specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Eur Urol. 2015 Sep;68(3):530-4. doi: 10.1016/j.eururo.2015.04.034.

73.    Gupta S, Madoff DC. Image-guided percutaneous needle biopsy in cancerdiagnosis and staging. Tech Vasc Interv Radiol. 2007 Jun;10(2):88-101. doi: 10.1053/j.tvir.2007.09.005.

74.    Higginson JA, Breik O, Thompson AH, Ashrafian H, Hardman JC, Takats Z, Paleri V, Dhanda J. Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: A meta-analysis. Oral Oncol. 2023 Jul;142:106419. doi: 10.1016/j.oraloncology.2023.106419.

75.    Dowling GP, Hehir CM, Daly GR, Hembrecht S, Keelan S, Giblin K, Alrawashdeh MM, Boland F, Hill ADK. Diagnostic accuracy of intraoperative methods for margin assessment in breast cancer surgery: A systematic review & meta-analysis. Breast. 2024 Aug;76:103749. doi: 10.1016/j.breast.2024.103749.

76.    Buckle T, van Alphen M, van Oosterom MN, van Beurden F, Heimburger N, van der Wal JE, van den Brekel M, van Leeuwen FWB, Karakullukcu B. Translation of c-Met Targeted Image-Guided Surgery Solutions in Oral Cavity Cancer-Initial Proof of Concept Data. Cancers (Basel). 2021 May 28;13(11):2674. doi: 10.3390/cancers13112674.

77.    Moraitis A, Kahl T, Kandziora J, Jentzen W, Kersting D, Püllen L, Reis H, Köllermann J, Kesch C, Krafft U, Hadaschik BA, Zaidi H, Herrmann K, Barbato F, Fendler WP, Darr C, Fragoso Costa P. Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and Their Prognostic Value in Radical Prostatectomy. J Nucl Med. 2025 Mar 3;66(3):352-358. doi: 10.2967/jnumed.124.268719.

78.    Darr C, Costa PF, Kahl T, Moraitis A, Engel J, Al-Nader M, Reis H, Köllermann J, Kesch C, Krafft U, Maurer T, Köhler D, Klutmann S, Falkenbach F, Kleesiek J, Fendler WP, Hadaschik BA, Herrmann K. Intraoperative Molecular Positro Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens. Eur Urol Open Sci. 2023 Jun 15;54:28-32. doi: 10.1016/j.euros.2023.05.017.

79.    Myers KS, Kamel IR, Macura KJ. MRI-guided breast biopsy: outcomes and effect on patient management. Clin Breast Cancer. 2015 Apr;15(2):143-52. doi: 10.1016/j.clbc.2014.11.003.

80.    Cerci JJ, Bogoni M, Cerci RJ, Masukawa M, Neto CCP, Krauzer C, Fanti S, Sakamoto DG, Barreiros RB, Nanni C, Vitola JV. PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results. J Nucl Med. 2021 Aug 1;62(8):1057-1061. Doi :10.2967/jnumed.120.252403.

81.    Tselikas L, Sun R, Ammari S, Dercle L, Yevich S, Hollebecque A, Ngo-Camus M, Nicotra C, Deutsch E, Deschamps F, de Baere T. Role of image-guided biopsy and radiomics in the age of precision medicine. Chin Clin Oncol. 2019 Dec;8(6):57. doi: 10.21037/cco.2019.12.02

82.    Sapienza MT. Radioguided localization of recurrent lymph nodes in differentiated thyroid cancer - Where are we now? Arch Endocrinol Metab. 2018 Oct;62(5):491-492. doi: 10.20945/2359-3997000000079.

83.     Collarino A, Valdés Olmos RA, van der Hoeven AF, Pereira Arias-Bouda LM. Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer. Clin Transl Imaging. 2016;4(5):367-376. doi: 10.1007/s40336-016-0201-z.

84.    Boni G, Mazzarri S, Grosso M, Manca G, Biricotti M, Ambrosini CE, Fregoli L, Puccini M, Caldarelli C, Spisni R. Sentinel node radioguided biopsy in surgical management of the medullary thyroid carcinoma A case report. Ann Ital Chir. 2014; 85(ePub):S2239253X14021963.PMID: 24556598

85.    de Las Fuentes Monreal M, Morales VC, Pérez IH, Villar IL, Hernández VE, Muñoz-Guerra MF. Radioguided Surgery for the Localisation of Specific Adenopathies in the Head and Neck Area. J Maxillofac Oral Surg. 2024 ;23(5):1289-1295. doi: 10.1007/s12663-023-01991-8.

86.    Vidal-Sicart S, Goñi E, Cebrecos I, Rioja ME, Perissinotti A, Sampol C, Vidal O, Saavedra-Pérez D, Ferrer A, Martí C, Ferrer Rebolleda J, García Velloso MJ, Orozco-Cortés J, Díaz-Feijóo B, Niñerola-Baizán A, Valdés Olmos RA. Continuous innovation in precision radio-guided surgery. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2024;43(1):39-54. doi: 10.1016/j.remnie.2023.11.001.

87.    Valdés Olmos RA, Vidal-Sicart S. Nuclear medicine contribution to precision surgery in breast cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 Sep- Oct;42(5):343-351. doi: 10.1016/j.remnie.2023.07.001.

88.    Niinikoski L, Hukkinen K, Leidenius MHK, Vaara P, Voynov A, Heikkilä P, et al. Resection margins and local recurrences of impalpable breast cancer: Comparison between radioguided occult lesion localization (ROLL) and radioactive seed localization (RSL). Breast 2019;47:93–101. doi.org/10.1016/j.breast.2019.07.004.

89.    Chow PK, Gandhi M, Gebski V. The SIRveNIB and SARAH trials and the role of SIR-Spheres® Y-90 resin microspheres in the management of hepatocellular carcinoma. Future Oncol. 2017 Oct;13(25):2213-2216. doi: 10.2217/fon-2017-0395.

90.    Salem R, Garin E, Boucher E, Fowers K, Lam M, Padia S, Harris W. Optimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety analyses from the EPOCH study. Oncologist. 2024 Aug 5;29(8):681-689. doi: 10.1093/oncolo/oyae128.

91.    Braat AJAT, Bruijnen RCG, van Rooij R, Braat MNGJA, Wessels FJ, van Leeuwaarde RS, van Treijen MJC, de Herder WW, Hofland J, Tesselaar MET, de Jong HWAM, Lam MGEH. Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study. Lancet Oncol. 2020 Apr;21(4):561-570. doi: 10.1016/S1470-2045(20)30027-9. 

92.    Sharon CE, Straker RJ 3rd, Gimotty PA, Chu EY, Mitchell TC, Miura JT, Marchetti MA, Bartlett EK, Karakousis GC. Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis. J Am Acad Dermatol. 2023 Apr;88(4):802-807. doi:10.1016/j.jaad.2022.11.033.

93.    Vázquez JC, Piñero A, de Castro FJ, Lluch A, Martín M, Barnadas A, Alba E, Rodríguez-Lescure Á, Rojo F, Giménez J, Solá I, Quintana MJ, Bonfill X, Urrutia G, Sánchez-Rovira P. The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview. Clin Transl Oncol. 2022 Sep;24(9):1744-1754.10.1007/s12094-022-02824-9

94.    Goyal A, Dodwell D. POSNOC: A randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. Breast Cancer Res Treat. 2024;193(2):321-330.10.1016/j.clon.2015.07.005

95.    van Leeuwen FWB, Buckle T, Rietbergen DDD, van Oosterom MN. The realization of medical devices for precision surgery - development and implementation of 'stop-and-go' imaging technologies. Expert Rev Med Devices. 2024 May;21(5):349-358. doi: 10.1080/17434440.2024.2341102.

96.    Van Oosterom, M.N., Azargoshasb, S., Slof, L.J, van Leeuwen FWB. Robotic radioguided surgery: toward full integration of radio- and hybrid-detection modalities. Clin Transl Imaging 2023;  11: 533–544. doi.org/10.1007/s40336-023-00560-w

97.    van Oosterom MN, Diaz-Feijóo B, Santisteban MI, Sánchez-Izquierdo N, Perissinotti A, Glickman A, Marina T, Torné A, van Leeuwen FWB, Vidal-Sicart S. Steerable DROP-IN radioguidance during minimal-invasive non-robotic cervical and endometrial sentinel lymph node surgery. Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3089-3097. doi: 10.1007/s00259-023-06589-3.

98.    Dell'Oglio P, Meershoek P, Maurer T, Wit EMK, van Leeuwen PJ, van der Poel HG, van Leeuwen FWB, van Oosterom MN. A DROP-IN Gamma Probe for Robot-assisted Radioguided Surgery of Lymph Nodes During Radical Prostatectomy. Eur Urol. 2021 Jan;79(1):124-132. doi: 10.1016/j.eururo.2020.10.031.

99.    van Leeuwen FWB, Buckle T, van Oosterom MN, Rietbergen DDD. The Rise of Molecular Image-Guided Robotic Surgery. J Nucl Med. 2024 Oct 1;65(10):1505-1511. doi: 10.2967/jnumed.124.267783.

100.    Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager DE, Osborne JR, Piert M, Rowe SP, Schöder H, Wan S, Wester HJ, Hope TA, Herrmann K. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486. doi: 10.1007/s00259-022-06089-w. 

101.    Lanfranco AR, Castellanos AE, Desai JP, Meyers WC. Robotic surgery: a current perspective. Ann Surg. 2004 Jan;239(1):14-21. doi: 10.1097/01.sla.0000103020.19595.7d.

102.    Baeten IGT, Hoogendam JP, Braat AJAT, Zweemer RP, Gerestein CG. Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer. EJNMMI Res. 2022 Jun 20;12(1):36. doi:10.1186/s13550-022-00907-w.

103.     Abascal Junquera JM, Harke NN, Walz JC, Hadaschik B, Adshead J, Everaerts W, Goffin K, Grootendorst MR, Oldfield F, Vyas K, Fusco AM, Juanpere N, Vidal-Sicart S, Fumado L. A Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer: Preclinical Evaluation and Interim Results From a Multicenter Clinical Trial. Clin Nucl Med. 2023 Mar 1;48(3):213-220. doi:10.1097/RLU.0000000000004557.

104.    Azargoshasb, S., de Barros, H.A., Rietbergen, D.D.D., Dell’Oglio, P., van Leeuwen, P.J., Wagner, C., Stricker, P., Vidal-Sicart, S., Briganti, A., Maurer, T., van der Poel, H.G., van Oosterom, M.N. and van Leeuwen, F.W.B. (2023), Artificial Intelligence-Supported Video Analysis as a Means to Assess the Impact of DROP-IN Image Guidance on Robotic Surgeons: Radioguided Sentinel Lymph Node versus PSMA-Targeted Prostate Cancer Surgery. Adv. Intell. Syst., 5: 2370044. https://doi.org/10.1002/aisy.202370044.

105.    Azargoshasb S, Berrens AC, Slof LJ, Sinaasappel M, van Leeuwen PJ, van der Poel HG, van Oosterom MN, van Leeuwen FWB. Robot-assisted Single Photon Emission Computed Tomography: Integrating Nuclear Medicine in Robotic Urologic Surgery. Eur Urol. 2024 May;85(5):503-505. doi: 10.1016/j.eururo.2024.01.022.

106.     Collamati F, van Oosterom MN, De Simoni M, Faccini R, Fischetti M, Mancini Terracciano C, Mirabelli R, Moretti R, Heuvel JO, Solfaroli Camillocci E, van Beurden F, van der Poel HG, Valdes Olmos RA, van Leeuwen PJ, van Leeuwen FWB, Morganti S. A DROP-IN beta probe for robot-assisted 68Ga-PSMA radioguided surgery: first ex vivo technology evaluation using prostate cancer specimens. EJNMMI Res. 2020 Aug 6;10(1):92. doi: 10.1186/s13550-020-00682-6.

107.     Weber WP, Davide Gentilini O, Morrow M, Montagna G, de Boniface J, Fitzal F, Wyld L, Rubio IT, Matrai Z, King TA, Saccilotto R, Galimberti V, Maggi N, Andreozzi M, Sacchini V, Castrezana López L, Loesch J, Schwab FD, Eller R, Heidinger M, Haug M, Kurzeder C, Di Micco R, Banys-Paluchowski M, Ditsch N, Harder Y, Paulinelli RR, Urban C, Benson J, Bjelic-Radisic V, Potter S, Knauer M, Thill M, Vrancken Peeters MJ, Kuemmel S, Heil J, Gulluoglu BM, Tausch C, Ganz Blaettler U, Shaw J, Dubsky P, Poortmans P, Kaidar-Person O, Kühn T, Gnant M. Uncertainties and controversies in axillary management of patients with breast cancer. Cancer Treat Rev. 2023 Jun;117:102556. doi: 10.1016/j.ctrv.2023.102556

108.     Oderda M, Grimaldi S, Rovera G, Delsedime L, D'Agate D, Lavagno F, Marquis A, Marra G, Molinaro L, Deandreis D, Gontero P. Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager. Urology. 2023 Dec;182:e257-e261. doi: 10.1016/j.urology.2023.08.013

109.     Delacroix D, Guerre JP, Leblanc P. Radionuclides and radiation protection practical guidebook - Third edition. Handbook for the handling of radioactive compounds in low and medium activity laboratories. Editions EDP Sciences; 2022.